Opthea

YTD

ALL

Why Robinhood?

You can watch Opthea and buy or sell other stocks, ETFs, and their options commission-free!

About OPT

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients.

CEO

Frédéric Guerard

CEOFrédéric Guerard

Employees

—

Employees—

Headquarters

South Yarra, Victoria (VIC)

HeadquartersSouth Yarra, Victoria (VIC)

Founded

1984

Founded1984

Employees

—

Employees—

OPT Key Statistics

Market cap

524.84M

Market cap524.84M

Price-Earnings ratio

-1.47

Price-Earnings ratio-1.47

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.30

52 Week high$6.30

52 Week low

$1.79

52 Week low$1.79

Analyst ratings

50%

of 6 ratings

Buy

16.7%

Hold

50%

Sell

33.3%